Obesity Flashcards
Overweight definition
Excessive body weight from ALL TISSUES
Obesity definition
Excessive amount of adipose tissue compared with lean tissue
Antiangiogenesis and poangiogeNesisdefinition
Look it up
3 FDA requirements for obesity drugs
1.5% reduction in total body weight maintained for 1 year OR 2. >35% of patients maintain 5% reduction in weight 3. Improve BP/lipids/blood glucose
Feeding behavior comes from what part of the brain
Hypothalamus
3 hormones that increase feeding
Neuropeptide Y AGRP Ghrelin
7 hormones that DEcrease feeding
a-MSH Lepton NEinsulin/amylin Cholecytokinin (CCK)/PYY CART
Leptin is released because of what
In proportion to fat
Pry/insulin/cck are released when
Upon digestion
When is ghrelin released
During fasting
Appetite Regulation

- Increase
- decrease
- increase
- POMC/CART
- AGRP/NPY
- Increase
- a-MSH
- Neurons of PVN
- Neuron
- decrease
POMC is produced where?
Pituitary
hypothalmush
brainstem
4 steps to decrease feeding
- Insulin/leptin/CCK are released and bind to receptors on AGRP/NPY or POMC/CART
- Leptin receptors release POMC and after enzymatic breakdown created a-MSH which decrased food intake
- a-MSH binds to the neuron receptor MCR-4
- sympathetic activity and energy expenditure are increased
4 steps to increase feeding
- Ghrelin is released
- Ghrelin stimulates Ghrelin hormone secretagogue receptor on AGRP/NPY
- Y1 receptor is stimulated in the neuron
- Food intake increased
Paraventricular Nucleus
(PVN)
send signals to the lateral hypothalamus to alter taste sensation and control autonomic responses such as digestive secretions
Orlistat (Alli)
5 MOA
2 recommendations
- inhibit lipase enzymes by binding to serine residues of enzyme active site
- prevent hydrolysis of TF to FFA (no activity on amylase/trypsin/chymotrypsin/phospholipases)
- TG excreted undigested
- REduces absorption of dietary fat
- decreases caloric intake
* BMI >30
*Diet that contains 30% calories from fat

Orlistat
Major SE of Orlistat
GAss
malabsorption of fat-soluble vitamins
Phenteramine 2 MOA
Duration of action
TAAR1 agnost: stimulates NE, 5-HT and DA release in hypothalamus
Stimulates sympathetic response
- inc. energy
- Ne activating B2-ARs in synapses inhibit appetite
*3 months

Phentermine
PHentermine & Topiramate (Qsymia)
SE
BMI >30
BMI >30 and weight related comorbidity
- HTN, DM2, Dylipidemia
SE: tertogenic possibly/ inc heart rate
Lorcaserin (Belviq)
MOA
- Agonist selective for 5-HT2c receptor highly expressed in POMC/CART neurons
- increses activity
- stimulate release of a-MSH
- decrease food intake

Lorcaserin
bupropion and naltrexone (contrave)
MOA
B: inhibit DA and NE uptake
N: u-opioid receptor antangonist